ns 1619 has been researched along with cyclic gmp in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armstead, WM | 2 |
Bryan, RM; Pelligrino, DA; Wang, Q | 1 |
Brakemeier, S; Eichler, I; Fassheber, T; Hoyer, J; Knorr, A; Köhler, R | 1 |
Angulo, J; Chen, M; Cuevas, P; Fernández, A; González-Corrochano, R; La Fuente, J; Sáenz de Tejada, I | 1 |
5 other study(ies) available for ns 1619 and cyclic gmp
Article | Year |
---|---|
Role of activation of calcium-sensitive K+ channels in NO- and hypoxia-induced pial artery vasodilation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Animals, Newborn; Arterioles; Benzimidazoles; Benzopyrans; Cerebral Arteries; Cromakalim; Cyclic GMP; Female; Hypoxia; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Penicillamine; Pia Mater; Potassium Channels; Pyrroles; S-Nitroso-N-Acetylpenicillamine; Swine; Vasodilation; Vasodilator Agents | 1997 |
Calcium-dependent and ATP-sensitive potassium channels and the 'permissive' function of cyclic GMP in hypercapnia-induced pial arteriolar relaxation.
Topics: Adenosine Triphosphate; Animals; Benzimidazoles; Blood Pressure; Calcium; Carbon Dioxide; Cerebral Arteries; Cromakalim; Cyclic GMP; Glyburide; Hydrogen-Ion Concentration; Hypercapnia; Indazoles; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Penicillamine; Peptides; Pia Mater; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Substrate Specificity; Vasodilation | 1998 |
Contribution of kca channel activation to hypoxic cerebrovasodilation does not involve NO.
Topics: Animals; Arteries; Benzimidazoles; Cerebrovascular Circulation; Cyclic GMP; Endorphins; Enzyme Inhibitors; Female; Hypoxia; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Nitric Oxide; Nitroarginine; Pia Mater; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Swine; Vasodilation | 1998 |
Modulation of Ca2+-activated K+ channel in renal artery endothelium in situ by nitric oxide and reactive oxygen species.
Topics: Animals; Benzimidazoles; Bradykinin; Cyclic GMP; Drug Combinations; Endothelium, Vascular; Large-Conductance Calcium-Activated Potassium Channels; Nitric Oxide; Nitric Oxide Donors; Patch-Clamp Techniques; Potassium Channels, Calcium-Activated; Reactive Oxygen Species; Renal Artery; Swine; Vasodilation | 2003 |
Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.
Topics: Adult; Aged; Animals; Benzimidazoles; Carbolines; Cyclic GMP; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electric Stimulation Therapy; Erectile Dysfunction; Humans; Male; Middle Aged; Nitric Oxide; Penis; Phosphodiesterase 5 Inhibitors; Piperazines; Potassium Channels, Calcium-Activated; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Tadalafil; Vasodilation; Vasodilator Agents | 2013 |